Search Results

101 - 110 of 359 items :

  • pharmacokinetics x
Clear All
Trends in vascular pharmacology research in the Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University, Bratislava

, Kriška M, Kovalčík V. (1978). Bayliss myogenic response in the isolated ductus arteriosus of guinea-pig and rabbit fetuses. Experientia   34 : 745-746. Turnheim K. (2003). When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol   38 : 843-853. Varga Z, Kriška M, Kristová V, Hudec. (2010). Prescription of NSAIDs and risk of cardiovascular adverse effects in hospitalized patients. Rheumatologia 24 : 87-90. Vojtko R., Villaris R., Petrová M., Líšková S

Open access
Analysis of Protein Adducts as Biomarkers of Short-Term Exposure to Ethylene Oxide and Results of Follow-Up Biomonitoring

, Törnqvist M, Kessler W, Ehrenberg L. Pharmacokinetics of ethylene oxide in man; body burden with ethylene oxide and hydroxyethylation of hemoglobin due to endogenous and environmental ethylene. Arch Toxicol 1992;66:157-63.

Open access
Acetylcholine and an acetylcholinesterase inhibitor neostigmine can aggravate tularemia progress in BALB/c mice

: 384-388. Yamamoto K, Sawada Y and Iga T. (1995). Comparative pharmacokinetics of four cholinesterase inhibitors in rats. Biol Pharm Bull   18 : 1292-1295. Yee D, Rhinebbart-Jones TR and Elkins L. (1996). Loss of either CD4+ or DC8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen Francisella tularensis strain LVS. J Immunol   157 : 5042-5048.

Open access
Can a Person with Attention Deficit Hyperactivity Disorder be an Athlete?

-Deficit Hyperactivity Disorder in Athletes, Curr Sports Med Rep. 2011;10(1):32-36. 23. Comiran E, Kessler FH, Fröehlich PE et al - Lisdexamfetamine: A pharmacokinetic review, Eur J Pharm Sci. 2016;89:172–179. 24. Garnock-Jones KP, Keating GM - Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents, Pediatr Drugs. 2009;11(3):203-226. 25. Strange BC– Once-daily treatment of ADHD with guanfacine: patient implications. Neuro psychiatr Dis Treat. 2008;4(3):499-506. 26. Söderlund GBW, Björk C, and Gustafsson P

Open access
Identification of peptide and protein doping related drug compounds confiscated in Denmark between 2007-2013

[12] Henninge J., Pepaj, M., Hullstein, I., Hemmersbach, P., Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation, Drug Test Analysis., 2010, 2, 647-650 [13] Mock S., Shen, X., Tamvakopoulos, C., Determination of melanotan-II in rat plasma by liquid chromatography/tandem mass spectrometry: determination of pharmacokinetic parameters in rat following intravenous administration, Rapid Commun. Mass Spectrom., 2002, 16, 2142-2147 [14] Tamvakopoulos C., Mass spectrometry for the

Open access
Evaluation of Teratogenic Activity of Antiepileptic Drug Lamotrigine in Mouse Fetuses

, Bastaki S, et al. Experimental studies on reproductive toxicologic effects of lamotrigine in mice. Birth Defects Res B Dev Reprod Toxicol 2003; 68(5): 428-38. 30. Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000; 41(6): 709-13. 31. Tunbridge EM, Attenburrow MJ, Gardiner A, et al. Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: Analysis of the CEQUEL clinical trial. Bipolar Disorders 2017; 19(6): 477

Open access
Platinum Complexes with Edda (Ethylenediamine -N, N - Diacetate) Ligands as Potential Anticancer Agents

-22. 21. Hamilton, G., & Olszewski, U. (2013). Picoplatin pharmacokinetics and chemotherapy of non-small cell lung cancer. Drug Evaluations. 9(10), 1381-1390. 22. Jakupec, M.A., Galanski, M., & Keppler, B.K. (2003). Tumor inhibiting platinum complexes- state of the art and future perspectives. Rev Physiol Biochem Pharmacol. 146, 1-53. 23. Armand, J.P., Bolgie, V., Raymond, E., Fizazi, K., Faivre, S., & Ducreux, M. (2000). Oxaliplatin in colorectal cancer: an overview. Semin Oncol., 27, 96-104. 24. Kelland, L. (2007). The

Open access
Developmentand Validation of a Questionnaire about Patient Knowledge of Adverse Effects of Statins

References 1. Bellosta S, Paoletti R, Corsini A. Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation. 2004;109(Suppl):III50-7. 2. Shankar-Hari M, Kruger PS, Di Gangi S et al. Statin therapy in critical illness: an international survey ofintensive care physicians’ opinions, attitudes and practice. BMC Clin Pharmacol. 2012;12:13-20. 3. Jukema JW, Cannon CP, de Craen AJ et al. The

Open access
Genotoxicity of sub-lethal di-n-butyl phthalate (DBP) in Nile tilapia (Oreochromis niloticus) / Genotoksičnost subletalne koncentracije di-n-butil ftalata (DBP-a) u nilskoj tilapiji (Oreochromis niloticus)

.613 5. Ventrice P, Ventrice D, Russo E, De Sarro G. Phthalates: European regulation, chemistry, pharmacokinetic and related toxicity. Environ Toxicol Pharmacol 2013;36:88-96. doi: 10.1016/j.etap.2013.03.014 6. Burridge LE, Haya K. A Review of di-n-butylphthalate in the aquatic environment: Concerns regarding its use in salmonid aquaculture. J World Aquacult Soc 1995;26:1-13. doi: 10.1111/j.1749-7345.1995.tb00203.x 7. Udroiu I. The micronucleus test in piscine erythrocytes. Aquat Toxicol 2006;79:201-4. doi:10.1016/j.aquatox.2006

Open access
Very long Detection Times after High and repeated intake of Heroin and Methadone, measured in Oral Fluid

by isotope-dilution electronimpact mass spectrometry. Clin Chem 39: 670-675. [18] Wang, W.L., Darwin, W.D., Cone, E.J. (1994) Simultaneous assay of cocaine, heroin and metabolites in hair, plasma, saliva and urine by gas chromatography-mass spectrometry. J Chromatogr. B Biomed. Appl 660: 279-290. [19] Kim, I., Barnes, A.J., Oyler, J.M., Schepers, R., Joseph, R.E., Jr., Cone, E.J. et al. (2002) Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration. Clin Chem 48: 1486-1496. [20

Open access